Armstrong Fleming & Moore Inc Makes New Investment in Markel Group Inc. (NYSE:MKL)

Armstrong Fleming & Moore Inc acquired a new stake in Markel Group Inc. (NYSE:MKL - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 164 shares of the insurance provider's stock, valued at approximately $307,000.

Other institutional investors have also recently modified their holdings of the company. Norges Bank bought a new stake in Markel Group during the fourth quarter worth about $254,795,000. GAMMA Investing LLC increased its holdings in Markel Group by 210,656.4% in the 1st quarter. GAMMA Investing LLC now owns 115,916 shares of the insurance provider's stock valued at $216,718,000 after buying an additional 115,861 shares during the period. Proficio Capital Partners LLC acquired a new position in shares of Markel Group in the 4th quarter valued at approximately $169,852,000. Davis Selected Advisers lifted its holdings in shares of Markel Group by 27.9% during the 4th quarter. Davis Selected Advisers now owns 370,522 shares of the insurance provider's stock worth $639,606,000 after acquiring an additional 80,922 shares during the period. Finally, Raymond James Financial Inc. bought a new stake in shares of Markel Group during the 4th quarter worth approximately $98,743,000. 77.12% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on MKL. Argus raised shares of Markel Group from a "hold" rating to a "buy" rating in a research note on Friday, May 30th. Royal Bank of Canada raised their target price on Markel Group from $1,750.00 to $2,025.00 and gave the company a "sector perform" rating in a report on Friday, February 7th. Finally, Wall Street Zen cut Markel Group from a "buy" rating to a "hold" rating in a report on Friday, February 14th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $1,727.75.

Insider Buying and Selling at Markel Group

In other news, Director Greta J. Harris sold 90 shares of the stock in a transaction on Friday, May 23rd. The stock was sold at an average price of $1,861.44, for a total value of $167,529.60. Following the completion of the transaction, the director now directly owns 632 shares in the company, valued at approximately $1,176,430.08. This represents a 12.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.66% of the company's stock.

Markel Group Trading Up 0.2%

Shares of Markel Group stock opened at $1,934.93 on Friday. The firm's 50 day moving average is $1,838.55 and its 200 day moving average is $1,815.36. The firm has a market capitalization of $24.54 billion, a PE ratio of 9.72 and a beta of 0.84. Markel Group Inc. has a 1 year low of $1,491.03 and a 1 year high of $2,063.68. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.26.

Markel Group Profile

Markel Group Inc, a diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany. The company offers general and professional liability, personal lines, marine and energy, specialty programs, and workers' compensation insurance products; and property coverages that include fire, allied lines, and other specialized property coverages, including catastrophe-exposed property risks, such as earthquake and wind.

Want to see what other hedge funds are holding MKL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Markel Group Inc. (NYSE:MKL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.